Core Insights - The Titan SGS™ Stapler is associated with significantly lower rates of postoperative gastroesophageal reflux disease (GERD) and shorter hospital stays compared to traditional multi-fire staplers in robotic-assisted laparoscopic sleeve gastrectomy (LSG) procedures [1][3][4] - A retrospective analysis of 257 patients showed that at one year post-procedure, 7.1% of patients using the Titan SGS™ Stapler reported GERD, compared to 26.4% in the multi-fire cohort [3][4] - The study highlights the importance of consistent surgical techniques in achieving better patient outcomes, particularly in reducing GERD incidence [2][3] Company Overview - Teleflex Incorporated is a leading global provider of medical technologies, focusing on improving health and quality of life through innovative solutions [5][6] - The Titan SGS™ Stapler is the first single-fire surgical stapler specifically designed for sleeve gastrectomy pouch creation, featuring a 23cm staple line for improved surgical outcomes [3][4] - The company aims to enhance the adoption of bariatric surgery by addressing common postoperative complications such as GERD [3][5]

Teleflex Incorporated (TFX) posted first-quarter 2025 adjusted earnings per share (EPS) from continuing operations of $2.91, down 9.3% from the year-ago quarter's figure. The metric topped the Zacks Consensus Estimate by 1%. GAAP EPS was $2.07 compared with $0.33 in the prior-year period. Following the announcement, shares of the company rose 0.4% last Friday. TFX's Revenues Net revenues fell 5% year over year (down 3.8% at constant exchange rate or CER) to $700.7 million. However, the metric surpassed the ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Teleflex Incorporated due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by a significant drop in Teleflex's stock price, which fell by 21.6% on February 27, 2025, following the announcement of a company split and a €760 million deal with Biotronik [3]. - Shareholders who purchased Teleflex securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering hundreds of millions for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, achieving the largest settlement against a Chinese company at the time and ranking highly in the number of settlements since 2013 [4].

NEW YORK, May 1, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public.So What: If you purchased Teleflex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Th ...

LOS ANGELES, May 1, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE: TFX) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Teleflex is the subject of an article published by Fierce Biotech on February 27 ...

For the quarter ended March 2025, Teleflex (TFX) reported revenue of $700.67 million, down 5% over the same period last year. EPS came in at $2.91, compared to $3.21 in the year-ago quarter.The reported revenue represents a surprise of +0.22% over the Zacks Consensus Estimate of $699.13 million. With the consensus EPS estimate being $2.88, the EPS surprise was +1.04%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expect ...

Teleflex (TFX) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy DevelopmentLiam Kelly - Chairman, President & CEOJohn Deren - EVP & CFOPatrick Wood - Managing DirectorJayson Bedford - Managing Director - Medical TechnologyAnthony Petrone - Managing DirectorRichard Newitter - Managing Director Conference Call Participants Michael Sarcone - AnalystVikramjeet Chopra - AnalystMatthew O'Brien - AnalystShagun Singh Chadha - Analy ...

Teleflex (TFX) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.88 per share. This compares to earnings of $3.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.04%. A quarter ago, it was expected that this medical equipment maker would post earnings of $3.86 per share when it actually produced earnings of $3.89, delivering a surprise of 0.78%.Over the last four quarters, the co ...

Teleflex (TFX) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy DevelopmentLiam Kelly - Chairman, President & CEOJohn Deren - EVP & CFOPatrick Wood - Managing DirectorJayson Bedford - Managing Director - Medical TechnologyAnthony Petrone - Managing DirectorRichard Newitter - Managing Director Conference Call Participants Michael Sarcone - AnalystVikramjeet Chopra - AnalystMatthew O'Brien - AnalystShagun Singh Chadha - Analy ...

Teleflex (TFX) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Speaker0 Good morning, ladies and gentlemen, and welcome to the Teleflex First Quarter twenty twenty five Earnings Conference Call. At this time, all participants have been placed in a listen only mode. At the end of the company's prepared remarks, we will conduct a question and answer session. Please note that this conference call is being recorded, and we will be available on the company's website for replay shortly. Now I will turn the call ov ...